ROZUCOR F 20

Rozucor F 20 Tablet is a pharmaceutical formulation that combines two medications designed to lower lipid levels, specifically cholesterol and triglycerides, in the bloodstream. This medication is indicated for patients who have not achieved adequate lipid reduction through lifestyle modifications alone, such as a low-fat diet. By effectively managing lipid levels, Rozucor F can help mitigate the risk of developing cardiovascular diseases. The tablet can be ingested with food or on an empty stomach, and it is advisable to take it at the same time each day to establish a consistent routine. The prescribing physician will determine the appropriate dosage based on individual lipid profile results and the patient’s response to the treatment. Many individuals with elevated cholesterol and triglycerides may not experience noticeable symptoms; however, discontinuation of the medication can lead to a spike in lipid levels, thus increasing the likelihood of heart disease and stroke. Regular monitoring of lipid profiles is essential during treatment with this medication. Rozucor F 20 Tablet is most effective when complemented by a balanced low-fat diet, physical activity, cessation of smoking, limited alcohol consumption, and weight management. While using this medication, patients are advised to maintain a regular diet but should avoid foods high in fats. Common adverse effects may include nausea, abdominal discomfort, constipation, headaches, gas, and muscle aches, which are usually mild and transient. If these effects persist or if side effects such as yellowing of the skin or eyes, unusual bleeding, or significant muscle pain occur, medical consultation is necessary. Routine liver function tests may be recommended during treatment. Patients with liver disease should not use this medication, and those with kidney issues or who are pregnant or breastfeeding need to discuss their conditions with a healthcare provider. Additionally, individuals with diabetes should keep track of their blood sugar levels, as the medication could potentially affect glucose levels.